Under Armour Inc Class A vs UnitedHealth Group Inc — how do they compare? Under Armour Inc Class A trades at $4.82 (market cap $2.15B), while UnitedHealth Group Inc trades at $394.18 (market cap $359.79B). The key difference: UnitedHealth Group Inc is far larger — about 167.3× Under Armour Inc Class A's market cap, and UnitedHealth Group Inc pays a 2.32% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| UA | UNH | |
|---|---|---|
Market Cap | $2.15B | $359.79B |
Sector | Consumer Cyclical | Health |
52-Week High | $7.88 | $436.35 |
52-Week Low | $3.96 | $259.02 |
Enterprise Value | $3.13B | $401.65B |
Dividend Yield | — | 2.32% |
Signals from Pluang's Aura AI — not financial advice
Under Armour (UA) trades at $4.95, down 3.32% amid bearish technical signals and weak fundamentals. The stock shows negative profitability with a net income margin of -9.99% and declining revenue trends. Recent earnings have been mixed, with Q2 2026 beating expectations but Q1 2026 missing. Cash flow remains negative, and the company faces challenges from softer consumer demand in key markets.
The outlook is cautious due to persistent revenue declines and negative margins. While analyst consensus leans slightly bullish with 40.3% buy ratings, significant risks include execution challenges and competitive pressures. Investors should weigh the potential for a turnaround against ongoing operational headwinds.
UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.
Trailing returns across standard periods
Latest headlines on both assets
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →